"In May, Healthy Vision Month, the National Eye Institute (NEI) calls on Americans to make their vision a priority by taking the necessary steps to protect vision, prevent vision loss, and make the most of the vision they may have remaining."...
ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formula or to other NSAIDs.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/4/2013
Additional Ilevro Information
Report Problems to the Food and Drug Administration
Get breaking medical news.